BD (NYSE:BDX) today announced that it has acquired resorbable polymer technology maker Tepha for an undisclosed amount.

Franklin Lakes, N.J.–based BD said that it will use Tepha’s resorbable polymer technology to accelerate the growth of the company’s business around surgical mesh for soft tissue repair, reconstruction and regeneration. Tepha’s GalaFlex portfolio is also included in the acquisition.

“This strategic acquisition advances BD’s category leadership in surgical mesh and enables future innovations to provide new solutions to physicians and their patients,” Kevin Kelly, worldwide president for BD Surgery, said in a news release. “Tepha’s proprietary polymer is used in BD’s current Phasix Mesh products and is the key technology that enables our products to provide short-term support for soft tissue repairs while enabling rapid tissue ingrowth and reabsorbing into the body over time. The acquisition — including its current and potential applications — will help ensure BD can continually provide physicians with the latest technology to treat their patients.”

GalaFlex products are a bioresorbable scaffold for soft tissue support and are designed to repair, elevate and reinforce deficiencies where weakness or voids exist that require additional material, according to the company.

“Our BD team has had a strong partnership with Tepha for more than 10 years, and we know their technology and people very well. We look forward to welcoming new, talented colleagues to the BD family,” Kelley said.

Tepha is the sixth acquisition BD has made in the fiscal year 2021.